A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)

NCT04573023 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

86

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis II

Interventions

DRUG: JR-141
DRUG: Idursulfase
DRUG: JR-141 or Idursulfase

Sponsor

JCR Pharmaceuticals Co., Ltd.